Discovery Elbow Long-Term Survivorship

March 20, 2017 updated by: Zimmer Biomet

Discovery Elbow Long-Term Survivorship Study

The Discovery™ Elbow Multi-Center Prospective Study (5-year Study) patients will be consented at the two year or next scheduled follow-up period for the early-enrolled patients.

Study Overview

Status

Terminated

Conditions

Detailed Description

Eligibility: Patient(s) must be enrolled in the Discovery Multi-Center Prospective Study. The patient must consent to participation in the Discovery Long-term Survivorship Study.

In order to continue to follow the multi-center subjects long-term Biomet would like to extend the follow-up to include annual follow-ups from 10 to 15 years to document long-term survivorship. The annual follow-up will be obtained by sending annual questionnaire directly to the patients by mail. The Patient ASES questionnaire and survivorship data questions will be collected.

Study Type

Observational

Enrollment (Actual)

29

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Florida
      • Tampa, Florida, United States, 33637
        • Florida Orthopedic Institute
    • Indiana
      • Indianapolis, Indiana, United States, 46260
        • The Indiana Hand to Shoulder Center
    • Massachusetts
      • Boston, Massachusetts, United States, 02114
        • Massachusetts General Hospital
    • Tennessee
      • Nashville, Tennessee, United States, 37232
        • Vanderbilt Hand Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The Study population shall be participanting in the Discovery Elbow Multi-center Study who provide consent for the Discovey Elbow Long-term Survivoship Study

Description

Inclusion Criteria:

  1. Participant in the Discovery Elbow Multi-center Study
  2. Consent to participate in the Discovery Elbow Long-Term Survivorship Study

Exclusion Criteria:

  1. Patient is not a Discovery Elbow Multi-center Participant
  2. Patient does not provide consent for the Discovery Elbow Long-term Survivorship Study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient Derived American Shoulder and Elbow Society (ASES) Pain Score
Time Frame: 10 Years Post-op
This is the patient's perception of pain related to the operative elbow. Maximum pain score = 50 (worst) Minimum pain score = 0 (best)
10 Years Post-op
Patient Derived American Shoulder and Elbow Society (ASES) Function
Time Frame: 10 Years Post-op
This is the patient's perception of function. The maximum score is 36 and the minimum score is 0. The maximum score represents maximum function.
10 Years Post-op
Patient Derived American Shoulder and Elbow Society (ASES) Satisfaction
Time Frame: 10 Years Post-op

This is the patient's perception of satisfaction with the elbow replacement surgery.

Maximum Score = 10 Minimum Score = 0 Maximum Score represents maximum satisfaction.

10 Years Post-op

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Survivorship Will be Measured by the Incidence of Revision or Removals
Time Frame: 10 years Post-op
The consented Patient will answer specific questions about their elbow replacement such as; if the elbow replacement has been removed
10 years Post-op

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Director: Russell Schenck, PhD, Director Clinical Research, Biomet Orthopedics, LLC

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2011

Primary Completion (Actual)

September 1, 2016

Study Completion (Actual)

September 1, 2016

Study Registration Dates

First Submitted

July 23, 2010

First Submitted That Met QC Criteria

March 2, 2011

First Posted (Estimate)

March 4, 2011

Study Record Updates

Last Update Posted (Actual)

May 1, 2017

Last Update Submitted That Met QC Criteria

March 20, 2017

Last Verified

March 1, 2017

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain

3
Subscribe